NCT06935513 Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
| NCT ID | NCT06935513 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Affiliated Hospital of Nantong University |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2025-04-20 |
| Primary Completion | 2025-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2025-04-20 with a primary completion date of 2025-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Eligibility Criteria
Inclusion Criteria: 1. Diagnosed with hypertension; 2. Diagnosed with diabetes; 3. Diagnosed with atrial fibrillation; 4. Smoking subjects; 5. Physical inactive subjects； 6. Obesity and overweight subjects; 7. Must be able to use smart wearable devices. Exclusion Criteria: 1. Diagnosed with malignancies; 2. Diagnosed with psychiatric disorders; 3. Diagnosed with cognitive impairment; 4. Unable to operate smart wearable devices.
Contact & Investigator
Qiuhong Ji, MD, PhD
STUDY CHAIR
Affiliated Hospital of Nantong University
Frequently Asked Questions
Who can join the NCT06935513 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06935513 currently recruiting?
Yes, NCT06935513 is actively recruiting participants. Contact the research team at jiqiuhong@ntu.edu.cn for enrollment information.
Where is the NCT06935513 trial being conducted?
This trial is being conducted at Nantong, China.
Who is sponsoring the NCT06935513 clinical trial?
NCT06935513 is sponsored by Affiliated Hospital of Nantong University. The principal investigator is Qiuhong Ji, MD, PhD at Affiliated Hospital of Nantong University. The trial plans to enroll 300 participants.